InvestorsHub Logo
icon url

CYDYWinning

06/08/20 6:31 AM

#83093 RE: Amatuer17 #83092

I’m confused why did you say 2021. July 10. Should be approved in November for HIV sales so 20 dollars a share easy by December 21.

What are you talking about ? Please explain your comment it doesn’t make sense.
icon url

JLA Ins

06/08/20 6:34 AM

#83094 RE: Amatuer17 #83092

Yeah this post makes no sense..
icon url

KCRoyal2004

06/08/20 6:51 AM

#83096 RE: Amatuer17 #83092

Amatuer17, in all fairness, the company was in a completely different situation in March 2019 (financially, as well as other relevant variables), and was only working toward HIV indication (there was no CV) at that time. If data results, from current trials, are as expected, approval will come WAY before 2021!
icon url

Venture_Cap

06/08/20 10:04 AM

#83156 RE: Amatuer17 #83092

They have a great drug but insufficient infrastructure to meet the demand. That’s the biggest concern right now... can the handle it?

Can they build out the company professionally and to scale?